<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 13 Aug 2026 12:47:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  10-Q       GUIDED THERAPEUTICS INC   For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++GUIDED+THERAPEUTICS+INC+++For%3A+Jun+30/26919256.html</link>
   <description>si-local-file:///var/storage/secattach/20260813/26919256.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++GUIDED+THERAPEUTICS+INC+++For%3A+Jun+30/26919256.html</guid>
   <pubDate>Thu, 13 Aug 2026 12:47:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	  </item>
  <item>
   <title>Form  10-Q       GUIDED THERAPEUTICS INC   For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++GUIDED+THERAPEUTICS+INC+++For%3A+Jun+30/26919256.html</link>
   <description>si-local-file:///var/storage/secattach/20260813/26919256.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++GUIDED+THERAPEUTICS+INC+++For%3A+Jun+30/26919256.html</guid>
   <pubDate>Thu, 13 Aug 2026 12:47:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	  </item>
  <item>
   <title>Guided Therapeutics receives $80,000 installment from Chinese distributor</title>
   <link>http://www.streetinsider.com/Corporate+News/Guided+Therapeutics+receives+%2480%2C000+installment+from+Chinese+distributor/26799078.html</link>
   <description>

&lt;p&gt;Guided Therapeutics, Inc. (OTCQB: GTHP) announced it received an $80,000 payment from Hangzhou Dongye Medical Technology Company Ltd (HDMT), representing the fourth installment of a $700,000 purchase order placed by the Chinese distributor.&lt;/p&gt;

&lt;p&gt;According to the company's press release, four LuViva Advanced Cervical Scan devices are expected to ship later this year, bringing the total number of devices shipped to 11 of the 35 devices due under the agreement. HDMT operates in Hangzhou City, Zhejiang Province, where it serves as the exclusive gynecology products provider for 42 hospitals that conduct approximately two million cervical cancer screenings annually.&lt;/p&gt;

&lt;p&gt;Guided Therapeutics also noted a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Guided+Therapeutics+receives+%2480%2C000+installment+from+Chinese+distributor/26799078.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:19 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics receives $80,000 installment from Chinese distributor</title>
   <link>http://www.streetinsider.com/Corporate+News/Guided+Therapeutics+receives+%2480%2C000+installment+from+Chinese+distributor/26799078.html</link>
   <description>

&lt;p&gt;Guided Therapeutics, Inc. (OTCQB: GTHP) announced it received an $80,000 payment from Hangzhou Dongye Medical Technology Company Ltd (HDMT), representing the fourth installment of a $700,000 purchase order placed by the Chinese distributor.&lt;/p&gt;

&lt;p&gt;According to the company's press release, four LuViva Advanced Cervical Scan devices are expected to ship later this year, bringing the total number of devices shipped to 11 of the 35 devices due under the agreement. HDMT operates in Hangzhou City, Zhejiang Province, where it serves as the exclusive gynecology products provider for 42 hospitals that conduct approximately two million cervical cancer screenings annually.&lt;/p&gt;

&lt;p&gt;Guided Therapeutics also noted a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Guided+Therapeutics+receives+%2480%2C000+installment+from+Chinese+distributor/26799078.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:19 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics receives $80,000 installment from Chinese distributor</title>
   <link>http://www.streetinsider.com/Corporate+News/Guided+Therapeutics+receives+%2480%2C000+installment+from+Chinese+distributor/26799078.html</link>
   <description>

&lt;p&gt;Guided Therapeutics, Inc. (OTCQB: GTHP) announced it received an $80,000 payment from Hangzhou Dongye Medical Technology Company Ltd (HDMT), representing the fourth installment of a $700,000 purchase order placed by the Chinese distributor.&lt;/p&gt;

&lt;p&gt;According to the company's press release, four LuViva Advanced Cervical Scan devices are expected to ship later this year, bringing the total number of devices shipped to 11 of the 35 devices due under the agreement. HDMT operates in Hangzhou City, Zhejiang Province, where it serves as the exclusive gynecology products provider for 42 hospitals that conduct approximately two million cervical cancer screenings annually.&lt;/p&gt;

&lt;p&gt;Guided Therapeutics also noted a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Guided+Therapeutics+receives+%2480%2C000+installment+from+Chinese+distributor/26799078.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:19 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor</title>
   <link>http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distribution partner Hangzhou Dongye Medical Technology Company Ltd (HDMT). The payment is the fourth installment of a $700,000 purchase order the Company received from HDMT last year.

&lt;/p&gt;&lt;p&gt;
The four LuViva devices are expected to ship later this year, which will bring the total number of devices shipped to eleven of the 35 devices due over the next several months. HDMT is in Hangzhou City, Zhejiang Province, where it is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor</title>
   <link>http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distribution partner Hangzhou Dongye Medical Technology Company Ltd (HDMT). The payment is the fourth installment of a $700,000 purchase order the Company received from HDMT last year.

&lt;/p&gt;&lt;p&gt;
The four LuViva devices are expected to ship later this year, which will bring the total number of devices shipped to eleven of the 35 devices due over the next several months. HDMT is in Hangzhou City, Zhejiang Province, where it is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor</title>
   <link>http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distribution partner Hangzhou Dongye Medical Technology Company Ltd (HDMT). The payment is the fourth installment of a $700,000 purchase order the Company received from HDMT last year.

&lt;/p&gt;&lt;p&gt;
The four LuViva devices are expected to ship later this year, which will bring the total number of devices shipped to eleven of the 35 devices due over the next several months. HDMT is in Hangzhou City, Zhejiang Province, where it is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor</title>
   <link>http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distribution partner Hangzhou Dongye Medical Technology Company Ltd (HDMT). The payment is the fourth installment of a $700,000 purchase order the Company received from HDMT last year.

&lt;/p&gt;&lt;p&gt;
The four LuViva devices are expected to ship later this year, which will bring the total number of devices shipped to eleven of the 35 devices due over the next several months. HDMT is in Hangzhou City, Zhejiang Province, where it is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor</title>
   <link>http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distribution partner Hangzhou Dongye Medical Technology Company Ltd (HDMT). The payment is the fourth installment of a $700,000 purchase order the Company received from HDMT last year.

&lt;/p&gt;&lt;p&gt;
The four LuViva devices are expected to ship later this year, which will bring the total number of devices shipped to eleven of the 35 devices due over the next several months. HDMT is in Hangzhou City, Zhejiang Province, where it is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor</title>
   <link>http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distribution partner Hangzhou Dongye Medical Technology Company Ltd (HDMT). The payment is the fourth installment of a $700,000 purchase order the Company received from HDMT last year.

&lt;/p&gt;&lt;p&gt;
The four LuViva devices are expected to ship later this year, which will bring the total number of devices shipped to eleven of the 35 devices due over the next several months. HDMT is in Hangzhou City, Zhejiang Province, where it is the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Receives+%2480%2C000+Payment+as+Fourth+Installment+of+%24700%2C000+Purchase+Order+with+Chinese+Distributor/26799058.html</guid>
   <pubDate>Wed, 22 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics signs new China distribution deal for LuViva device</title>
   <link>http://www.streetinsider.com/Corporate+News/Guided+Therapeutics+signs+new+China+distribution+deal+for+LuViva+device/26765906.html</link>
   <description>&lt;p&gt;Guided Therapeutics, Inc. (OTCQB: GTHP) announced a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply LuViva Advanced Cervical Scan instruments, single-use components, and support services in China.&lt;/p&gt;&lt;p&gt;Under the agreement, Guided Therapeutics will receive payments and parts from China valued at approximately $300,000. Upon approval by China's National Medical Products Administration (NMPA), the company will execute a purchase order for 50 LuViva systems and 500,000 single-use components. In return, Guided Therapeutics will provide services and specialized parts needed for a manufacturing inspection by the NMPA. A successful inspection is expected to lead to NMPA approval for marketing and sale</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Guided+Therapeutics+signs+new+China+distribution+deal+for+LuViva+device/26765906.html</guid>
   <pubDate>Tue, 14 Jul 2026 09:03:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics signs new China distribution deal for LuViva device</title>
   <link>http://www.streetinsider.com/Corporate+News/Guided+Therapeutics+signs+new+China+distribution+deal+for+LuViva+device/26765906.html</link>
   <description>&lt;p&gt;Guided Therapeutics, Inc. (OTCQB: GTHP) announced a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply LuViva Advanced Cervical Scan instruments, single-use components, and support services in China.&lt;/p&gt;&lt;p&gt;Under the agreement, Guided Therapeutics will receive payments and parts from China valued at approximately $300,000. Upon approval by China's National Medical Products Administration (NMPA), the company will execute a purchase order for 50 LuViva systems and 500,000 single-use components. In return, Guided Therapeutics will provide services and specialized parts needed for a manufacturing inspection by the NMPA. A successful inspection is expected to lead to NMPA approval for marketing and sale</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Guided+Therapeutics+signs+new+China+distribution+deal+for+LuViva+device/26765906.html</guid>
   <pubDate>Tue, 14 Jul 2026 09:03:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation</title>
   <link>http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had reached a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply them with LuViva instruments, single-use components and support services.

&lt;/p&gt;&lt;p&gt;
YMIC is headquartered in Jiangsu province, China, home to 137 million women eligible for testing with LuViva and is licensed by the Chinese government to sell and distribute both Class II and Class III medical devices. According to the new agreement, GTI will receive payments and parts from China valued at approximately $300,000 and, upon approval by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</guid>
   <pubDate>Tue, 14 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation</title>
   <link>http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had reached a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply them with LuViva instruments, single-use components and support services.

&lt;/p&gt;&lt;p&gt;
YMIC is headquartered in Jiangsu province, China, home to 137 million women eligible for testing with LuViva and is licensed by the Chinese government to sell and distribute both Class II and Class III medical devices. According to the new agreement, GTI will receive payments and parts from China valued at approximately $300,000 and, upon approval by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</guid>
   <pubDate>Tue, 14 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation</title>
   <link>http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had reached a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply them with LuViva instruments, single-use components and support services.

&lt;/p&gt;&lt;p&gt;
YMIC is headquartered in Jiangsu province, China, home to 137 million women eligible for testing with LuViva and is licensed by the Chinese government to sell and distribute both Class II and Class III medical devices. According to the new agreement, GTI will receive payments and parts from China valued at approximately $300,000 and, upon approval by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</guid>
   <pubDate>Tue, 14 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation</title>
   <link>http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had reached a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply them with LuViva instruments, single-use components and support services.

&lt;/p&gt;&lt;p&gt;
YMIC is headquartered in Jiangsu province, China, home to 137 million women eligible for testing with LuViva and is licensed by the Chinese government to sell and distribute both Class II and Class III medical devices. According to the new agreement, GTI will receive payments and parts from China valued at approximately $300,000 and, upon approval by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</guid>
   <pubDate>Tue, 14 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation</title>
   <link>http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had reached a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply them with LuViva instruments, single-use components and support services.

&lt;/p&gt;&lt;p&gt;
YMIC is headquartered in Jiangsu province, China, home to 137 million women eligible for testing with LuViva and is licensed by the Chinese government to sell and distribute both Class II and Class III medical devices. According to the new agreement, GTI will receive payments and parts from China valued at approximately $300,000 and, upon approval by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</guid>
   <pubDate>Tue, 14 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation</title>
   <link>http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had reached a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) to supply them with LuViva instruments, single-use components and support services.

&lt;/p&gt;&lt;p&gt;
YMIC is headquartered in Jiangsu province, China, home to 137 million women eligible for testing with LuViva and is licensed by the Chinese government to sell and distribute both Class II and Class III medical devices. According to the new agreement, GTI will receive payments and parts from China valued at approximately $300,000 and, upon approval by</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Guided+Therapeutics+Announces+New+Agreement+with+Distribution+Partner+Yuanshuo+Medical+Instruments+Corporation/26765750.html</guid>
   <pubDate>Tue, 14 Jul 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QB</category>
   	  </item>
  <item>
   <title>GUIDED THERAPEUTICS files cervical cancer device clinical report with FDA</title>
   <link>http://www.streetinsider.com/FDA/GUIDED+THERAPEUTICS+files+cervical+cancer+device+clinical+report+with+FDA/26651399.html</link>
   <description>

&lt;p&gt;Guided Therapeutics, Inc. (OTCQB: GTHP) has filed the clinical trial results for its LuViva Advanced Cervical Scan device with the U.S. Food and Drug Administration as part of a Premarket Approval Application.&lt;/p&gt;

&lt;p&gt;The multicenter study, developed in coordination with the FDA, enrolled 480 women referred to biopsy due to abnormal Pap and/or HPV tests. Of the 428 women who completed the study, 99 were determined by independent pathology to have significant cervical disease. The company said 32 of those cases, or 32.3%, went undetected by the current standard of care, colposcopy-directed biopsy.&lt;/p&gt;

&lt;p&gt;According to the press release, LuViva detected 21 of those</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/GUIDED+THERAPEUTICS+files+cervical+cancer+device+clinical+report+with+FDA/26651399.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:00:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	  </item>
  <item>
   <title>GUIDED THERAPEUTICS files cervical cancer device clinical report with FDA</title>
   <link>http://www.streetinsider.com/FDA/GUIDED+THERAPEUTICS+files+cervical+cancer+device+clinical+report+with+FDA/26651399.html</link>
   <description>

&lt;p&gt;Guided Therapeutics, Inc. (OTCQB: GTHP) has filed the clinical trial results for its LuViva Advanced Cervical Scan device with the U.S. Food and Drug Administration as part of a Premarket Approval Application.&lt;/p&gt;

&lt;p&gt;The multicenter study, developed in coordination with the FDA, enrolled 480 women referred to biopsy due to abnormal Pap and/or HPV tests. Of the 428 women who completed the study, 99 were determined by independent pathology to have significant cervical disease. The company said 32 of those cases, or 32.3%, went undetected by the current standard of care, colposcopy-directed biopsy.&lt;/p&gt;

&lt;p&gt;According to the press release, LuViva detected 21 of those</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/GUIDED+THERAPEUTICS+files+cervical+cancer+device+clinical+report+with+FDA/26651399.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:00:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	  </item>
  <item>
   <title>GUIDED THERAPEUTICS files cervical cancer device clinical report with FDA</title>
   <link>http://www.streetinsider.com/FDA/GUIDED+THERAPEUTICS+files+cervical+cancer+device+clinical+report+with+FDA/26651399.html</link>
   <description>

&lt;p&gt;Guided Therapeutics, Inc. (OTCQB: GTHP) has filed the clinical trial results for its LuViva Advanced Cervical Scan device with the U.S. Food and Drug Administration as part of a Premarket Approval Application.&lt;/p&gt;

&lt;p&gt;The multicenter study, developed in coordination with the FDA, enrolled 480 women referred to biopsy due to abnormal Pap and/or HPV tests. Of the 428 women who completed the study, 99 were determined by independent pathology to have significant cervical disease. The company said 32 of those cases, or 32.3%, went undetected by the current standard of care, colposcopy-directed biopsy.&lt;/p&gt;

&lt;p&gt;According to the press release, LuViva detected 21 of those</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/GUIDED+THERAPEUTICS+files+cervical+cancer+device+clinical+report+with+FDA/26651399.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:00:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	  </item>
  <item>
   <title>GUIDED THERAPEUTICS files cervical cancer device clinical report with FDA</title>
   <link>http://www.streetinsider.com/FDA/GUIDED+THERAPEUTICS+files+cervical+cancer+device+clinical+report+with+FDA/26651399.html</link>
   <description>

&lt;p&gt;Guided Therapeutics, Inc. (OTCQB: GTHP) has filed the clinical trial results for its LuViva Advanced Cervical Scan device with the U.S. Food and Drug Administration as part of a Premarket Approval Application.&lt;/p&gt;

&lt;p&gt;The multicenter study, developed in coordination with the FDA, enrolled 480 women referred to biopsy due to abnormal Pap and/or HPV tests. Of the 428 women who completed the study, 99 were determined by independent pathology to have significant cervical disease. The company said 32 of those cases, or 32.3%, went undetected by the current standard of care, colposcopy-directed biopsy.&lt;/p&gt;

&lt;p&gt;According to the press release, LuViva detected 21 of those</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/GUIDED+THERAPEUTICS+files+cervical+cancer+device+clinical+report+with+FDA/26651399.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:00:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA</title>
   <link>http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Files+Premarket+Approval+Application+Clinical+Report+with+FDA/26651348.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, announced today it had filed the results of its multicenter clinical trial with the U.S. Food and Drug Administration (FDA).

&lt;/p&gt;&lt;p&gt;
The study protocol was developed through interactions with FDA and enrolled 480 women referred to biopsy because of abnormal Pap and/or HPV tests. Of the 428 women that completed the study, 99 were determined by expert independent pathology to have significant cervical disease that can</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Files+Premarket+Approval+Application+Clinical+Report+with+FDA/26651348.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	  </item>
  <item>
   <title>Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA</title>
   <link>http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Files+Premarket+Approval+Application+Clinical+Report+with+FDA/26651348.html</link>
   <description>
&lt;p&gt;    PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, announced today it had filed the results of its multicenter clinical trial with the U.S. Food and Drug Administration (FDA).

&lt;/p&gt;&lt;p&gt;
The study protocol was developed through interactions with FDA and enrolled 480 women referred to biopsy because of abnormal Pap and/or HPV tests. Of the 428 women that completed the study, 99 were determined by expert independent pathology to have significant cervical disease that can</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Guided+Therapeutics+Files+Premarket+Approval+Application+Clinical+Report+with+FDA/26651348.html</guid>
   <pubDate>Tue, 16 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00172307</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	  </item>
 </channel>
</rss>
